Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate

Fig. 1

Exemplary cumulative DVH of fraction 2 of patient 32 under the adaptive workflow (abdominal lymph node treatment with a dose prescription of 5 × 5.0 Gy to the 80% isodose); re-optimized (re., solid lines) and predicted (pr., dashed lines). Target coverage increased after plan adaption while OAR exposure could be reduced. *Common bile duct

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us